Aug 28, 2018 8:00am EDT OPKO Health’s BioReference Laboratories to Participate in the National Cancer Institute NCI-MATCH (Molecular Analysis for Therapy Choice) Phase II Clinical Trial
Aug 03, 2018 1:29pm EDT OPKO Health Completes Enrollment in Global Phase 3 Study of Somatrogon (hGH-CTP) in Growth Hormone Deficient Children
Aug 02, 2018 8:00am EDT OPKO Health to Announce Second Quarter 2018 Financial Results on August 7, 2018
Jul 16, 2018 11:57am EDT OPKO Partner Vifor Fresenius Receives Marketing Approval for RAYALDEE in Canada
Jun 11, 2018 8:00am EDT OPKO Health Completes Enrollment in Phase 2b Study of OPK88003 to Treat Type 2 Diabetes and Obesity
May 18, 2018 9:12am EDT OPKO Plans to Address Draft Local Coverage Determination Published by Novitas Solutions for 4Kscore Test